{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:52:32Z","timestamp":1791474752413,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.immuni.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T10:32:31Z","timestamp":1644489151000},"page":"459-474.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Interferon-\u03b2 acts directly on T\u00a0cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation"],"prefix":"10.1016","volume":"55","author":[{"given":"Francisco","family":"Fueyo-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"McGinty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-3508","authenticated-orcid":false,"given":"Mehek","family":"Ningoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0006-0308","authenticated-orcid":false,"given":"Lisa","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cantarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Andrea Angeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Llaud\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Purroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Heja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Sealfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Heeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-0923","authenticated-orcid":false,"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1804-8136","authenticated-orcid":false,"given":"Miguel","family":"Fribourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2022.01.011_bib1","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1172\/JCI29251","article-title":"Alterations in CD46-mediated Tr1 regulatory T\u00a0cells in patients with multiple sclerosis","volume":"116","author":"Astier","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2022.01.011_bib2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2022.01.011_bib3","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.01.011_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2011.02.017","article-title":"Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T\u00a0cells","volume":"34","author":"Bandukwala","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2022.01.011_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sj\u00f6gren\u2019s syndrome: a possible etiopathogenic mechanism","volume":"52","author":"B\u00e5ve","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.immuni.2022.01.011_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/jir.2010.0091","article-title":"Critical review: assessment of interferon-\u03b2 immunogenicity in multiple sclerosis","volume":"30","author":"Bendtzen","year":"2010","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.immuni.2022.01.011_bib7","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2022.01.011_bib8","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.4049\/jimmunol.181.10.6872","article-title":"Antiviral-activated dendritic cells: a paracrine-induced response state","volume":"181","author":"Border\u00eda","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T\u00a0cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003027","article-title":"Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T\u00a0cell differentiation and phenotype plasticity","volume":"9","author":"Carbo","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.immuni.2022.01.011_bib11","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1601896","article-title":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection","volume":"198","author":"Channappanavar","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4049\/jimmunol.179.2.854","article-title":"KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in\u00a0vitro","volume":"179","author":"Chewning","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.169.1.522","article-title":"Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles","volume":"169","author":"Christopher","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.immuni.2015.05.009","article-title":"DC-SIGN(+) macrophages control the induction of transplantation tolerance","volume":"42","author":"Conde","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2022.01.011_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri3806","article-title":"Regulation of antiviral T\u00a0cell responses by type I interferons","volume":"15","author":"Crouse","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003962","article-title":"Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency","volume":"10","author":"Da\u011f","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.immuni.2022.01.011_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41598-019-57294-x","article-title":"HDAC10 deletion promotes Foxp3+ T-regulatory cell function","volume":"10","author":"Dahiya","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2022.01.011_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2006.09.012","article-title":"Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex\u00a0vivo and in\u00a0vitro longitudinal study in relapsing-remitting multiple sclerosis","volume":"182","author":"de Andr\u00e9s","year":"2007","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib19","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1074\/jbc.M807322200","article-title":"Foxp3 processing by proprotein convertases and control of regulatory T\u00a0cell function","volume":"284","author":"de Zoeten","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2022.01.011_bib20","article-title":"An inflammatory cytokine signature helps predict COVID-19 severity and death","author":"Del Valle","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.immuni.2022.01.011_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13550280601094563","article-title":"JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls","volume":"13","author":"Delbue","year":"2007","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.immuni.2022.01.011_bib22","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1128\/JVI.00656-06","article-title":"Human CD4+ CD25 high cells suppress proliferative memory lymphocyte responses to herpes simplex virus type 2","volume":"80","author":"Diaz","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.01.011_bib23","article-title":"Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease","volume":"5","author":"Donadei","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2022.01.011_bib24","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1111\/ajt.14467","article-title":"Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts","volume":"17","author":"Fabritius","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.immuni.2022.01.011_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-5728(02)00098-X","article-title":"Interferon-beta directly influences monocyte infiltration into the central nervous system","volume":"127","author":"Floris","year":"2002","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1023\/A:1026625928117","article-title":"Differences between interferon-alpha and -beta treatment for patients with chronic hepatitis C virus infection","volume":"44","author":"Furusyo","year":"1999","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.immuni.2022.01.011_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2022.01.011_bib28","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1073\/pnas.0701266104","article-title":"Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus","volume":"104","author":"Graham","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.01.011_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.immuni.2022.01.011_bib30","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1097\/TP.0000000000001436","article-title":"CD4+CD25+ T regulatory cells in transplantation tolerance: 25 years on","volume":"100","author":"Hall","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.immuni.2022.01.011_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","article-title":"Type I interferons: crucial participants in disease amplification in autoimmunity","volume":"6","author":"Hall","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.immuni.2022.01.011_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056527","article-title":"Interferon-\u03b1 is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers","volume":"8","author":"Hardy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.immuni.2022.01.011_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri3463","article-title":"25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end","volume":"13","author":"Heim","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.immuni.2022.01.011_bib35","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1128\/JVI.01459-15","article-title":"Type I interferon released by myeloid dendritic cells reversibly impairs cytomegalovirus replication by inhibiting immediate early gene expression","volume":"89","author":"Holzki","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.01.011_bib36","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","article-title":"COPASI\u2014a complex pathway simulator","volume":"22","author":"Hoops","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2022.01.011_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-6527-4_21","article-title":"Proximity ligation assay to quantify Foxp3 acetylation in regulatory T\u00a0cells","volume":"1510","author":"Jiao","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2022.01.011_bib39","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1172\/JCI88169","article-title":"Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression","volume":"128","author":"Kawano","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2022.01.011_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T\u00a0cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/bs.aivir.2016.08.006","article-title":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response","volume":"96","author":"Kindler","year":"2016","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.immuni.2022.01.011_bib42","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archneur.65.11.1434","article-title":"Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T\u00a0cells","volume":"65","author":"Korporal","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.immuni.2022.01.011_bib43","first-page":"CD009333","article-title":"Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis","volume":"11","author":"La Mantia","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.immuni.2022.01.011_bib44","first-page":"1838","article-title":"Efficacy and safety of interferon beta-1b sc in older RRMS patients\u2014a posthoc analysis of the BEYOND study","volume":"260","author":"Lampl","year":"2013","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.immuni.2022.01.011_bib45","article-title":"Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.immuni.2022.01.011_bib46","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ajt.15072","article-title":"C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival","volume":"19","author":"Llaudo","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.immuni.2022.01.011_bib47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature05478","article-title":"Foxp3 occupancy and regulation of key target genes during T-cell stimulation","volume":"445","author":"Marson","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.01.011_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2009.10.013","article-title":"Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T\u00a0cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study","volume":"218","author":"Namdar","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2015.12.027","article-title":"Alpha and beta Type 1 interferon signaling: passage for diverse biologic outcomes","volume":"164","author":"Ng","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2022.01.011_bib50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chom.2015.04.005","article-title":"Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection","volume":"17","author":"Ng","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2022.01.011_bib51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-6143.2009.02871.x","article-title":"Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T\u00a0cells","volume":"10","author":"Oberbarnscheidt","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.immuni.2022.01.011_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virusres.2007.11.002","article-title":"Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus","volume":"132","author":"O'Hara","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.immuni.2022.01.011_bib53","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.20132577","article-title":"Interplay between regulatory T\u00a0cells and PD-1 in modulating T\u00a0cell exhaustion and viral control during chronic LCMV infection","volume":"211","author":"Penaloza-MacMaster","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2022.01.011_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2893.1995.tb00014.x","article-title":"Clinical efficacy of intramuscular human interferon-beta vs interferon-alpha 2b for the treatment of chronic hepatitis C","volume":"2","author":"P\u00e9rez","year":"1995","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.immuni.2022.01.011_bib55","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1681\/ASN.2016101100","article-title":"Erythropoietin receptor-mediated molecular crosstalk promotes T\u00a0cell immunoregulation and transplant survival","volume":"28","author":"Purroy","year":"2017","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.immuni.2022.01.011_bib56","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1128\/JVI.00199-16","article-title":"Type I interferons regulate the magnitude and functionality of mouse polyomavirus-specific CD8 T\u00a0cells in a virus strain-dependent manner","volume":"90","author":"Qin","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.01.011_bib57","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MOT.0000000000000212","article-title":"New insights into the mechanisms of Treg function","volume":"20","author":"Rothstein","year":"2015","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.immuni.2022.01.011_bib58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.410400412","article-title":"Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis","volume":"40","author":"Rudick","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.immuni.2022.01.011_bib59","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-stimulated genes: what do they all do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.immuni.2022.01.011_bib60","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fimmu.2018.01048","article-title":"Foxp3+ T regulatory cells: still many unanswered questions-a perspective after 20yearsof study","volume":"9","author":"Shevach","year":"2018","journal-title":"Front .Immunol ."},{"key":"10.1016\/j.immuni.2022.01.011_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T\u00a0cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I interferon in chronic virus infection and cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.immuni.2022.01.011_bib63","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.celrep.2012.04.012","article-title":"Structural and biological features of FOXP3 dimerization relevant to regulatory T\u00a0cell function","volume":"1","author":"Song","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.immuni.2022.01.011_bib64","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1172\/JCI65180","article-title":"Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation","volume":"123","author":"Stewart","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2022.01.011_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2249.2000.01144.x","article-title":"Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection","volume":"119","author":"Stylianou","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib66","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.01.011_bib67","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T\u00a0cells","volume":"13","author":"Tao","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2022.01.011_bib68","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.4049\/jimmunol.0903324","article-title":"FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes","volume":"184","author":"Tartar","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib69","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.4049\/jimmunol.177.6.3542","article-title":"IFN-beta inhibits T\u00a0cell activation capacity of central nervous system APCs","volume":"177","author":"Teige","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.01.011_bib71","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1128\/JVI.78.23.13082-13089.2004","article-title":"CD4+ CD25+ T\u00a0cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1","volume":"78","author":"Toka","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.01.011_bib72","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.4049\/jimmunol.163.11.6306","article-title":"Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus","volume":"163","author":"Vallin","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib73","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","article-title":"Complex modulation of cell type-specific signaling in response to type I interferons","volume":"25","author":"van Boxel-Dezaire","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2022.01.011_bib74","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.1300847","article-title":"Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T\u00a0cells","volume":"190","author":"van der Touw","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib75","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.it.2014.06.005","article-title":"Post-translational modification networks regulating FOXP3 function","volume":"35","author":"van Loosdregt","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.immuni.2022.01.011_bib76","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2013.05.018","article-title":"Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity","volume":"39","author":"van Loosdregt","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2022.01.011_bib77","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization","volume":"115","author":"van Loosdregt","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2022.01.011_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.08.007","article-title":"Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis","volume":"215","author":"Vandenbark","year":"2009","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib79","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.immuni.2022.01.011_bib80","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.4049\/jimmunol.1500411","article-title":"IFN-\u03b2 facilitates neuroantigen-dependent induction of CD25+ FOXP3+ regulatory T\u00a0cells that suppress experimental autoimmune encephalomyelitis","volume":"197","author":"Wang","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4049\/jimmunol.1001473","article-title":"The role of glycogen synthase kinase 3 in regulating IFN-\u03b2-mediated IL-10 production","volume":"186","author":"Wang","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib82","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chom.2012.05.003","article-title":"Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T\u00a0cell exhaustion and chronic viral infection","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2022.01.011_bib83","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2007.03.023","article-title":"Quantification and localisation of Foxp3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection","volume":"47","author":"Ward","year":"2007","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.immuni.2022.01.011_bib84","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1084\/jem.20120914","article-title":"Neuropilin 1 is expressed on thymus-derived natural regulatory T\u00a0cells, but not mucosa-generated induced Foxp3+ T reg cells","volume":"209","author":"Weiss","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2022.01.011_bib85","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.celrep.2014.04.021","article-title":"Dynamic interactions between TIP60 and p300 regulate FOXP3 function through a structural switch defined by a single lysine on TIP60","volume":"7","author":"Xiao","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.immuni.2022.01.011_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005251","article-title":"The regulatory T\u00a0cell lineage factor Foxp3 regulates gene expression through several distinct mechanisms mostly independent of direct DNA binding","volume":"11","author":"Xie","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.immuni.2022.01.011_bib87","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.20120822","article-title":"Neuropilin-1 distinguishes natural and inducible regulatory T\u00a0cells among regulatory T\u00a0cell subsets in\u00a0vivo","volume":"209","author":"Yadav","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2022.01.011_bib88","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.1100056","article-title":"The novel costimulatory programmed death ligand 1\/B7.1 pathway is functional in inhibiting alloimmune responses in\u00a0vivo","volume":"187","author":"Yang","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib89","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.4049\/jimmunol.173.12.7115","article-title":"Cutting edge: TLR4 activation mediates liver ischemia\/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway","volume":"173","author":"Zhai","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.01.011_bib90","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nature05563","article-title":"Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T\u00a0cells","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:16:59Z","timestamp":1761034619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761322000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1074761322000401"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2022.01.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741615236.793592497","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b2 acts directly on T\u00a0cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}